Draft:Genomes.io
| Submission rejected on 24 July 2025 by S0091 (talk). This topic is not sufficiently notable for inclusion in Wikipedia. Rejected by S0091 5 days ago. Last edited by S0091 5 days ago. |  |
| Submission declined on 24 July 2025 by Pythoncoder (talk).Pythoncoder 5 days ago. |  |
| Submission declined on 24 July 2025 by DoubleGrazing (talk). This draft's references do not show that the subject qualifies for a Wikipedia article. In summary, the draft needs multiple published sources that are: Declined by DoubleGrazing 5 days ago.
| |
Comment: What they say about themselves is not useful. The only source that might meet the criteria is WHYY but still most of that is based on what those involved with Genomes.io say so weak. S0091 (talk) 17:26, 24 July 2025 (UTC)
Genomes.io
[edit]Genomes.io is a biotechnology company based in London that develops tools for privacy-focused genomic data management. Founded in 2018, the company offers whole genome sequencing and encrypted storage solutions using blockchain technology. Genomes.io has been featured in media outlets such as Forbes, Cointelegraph, NPR-affiliated WHYY, and Labiotech.eu.[1]
History
[edit]Genomes.io was co-founded in 2018 by Aldo de Pape and Mark Hahnel.[1] In 2018, the company launched a crowdfunding campaign to support further development of its proof of concept.
In March 2023, Aldo de Pape delivered a lecture at Bermuda College on the topic of genetic data ownership and privacy.[2]
A 2024 article in Cointelegraph reported that Genomes.io experienced a rise in sign-ups following the bankruptcy of 23andMe.[3] This trend was further noted in subsequent coverage linking the company to broader efforts in blockchain-based genomics platforms.[4]
Technology
[edit]Genomes.io provides whole genome sequencing at 30x coverage. The resulting data is stored in what the company refers to as a "genomic vault," which uses encryption and blockchain-based infrastructure to enable consent-based data access.[3] Users are notified when researchers query their data and can approve or deny access.
The company uses a utility token, $GENOME, to manage data access transactions.[5] Genomes.io operates with decentralized governance and is built on Ethereum's blockchain infrastructure.[6]
Media Coverage and Recognition
[edit]In 2022, the company received the Deloitte Tech Fast 50 Challenge Award, recognizing emerging technology ventures.[7] It has been included in discussions on blockchain's role in scientific innovation.[8]
The platform has been discussed in several outlets including Forbes,[1] Cointelegraph,[3][4][8] WHYY,[5] Labiotech.eu,[6] and Felix Online.[9]
See also
[edit]- Decentralized science
- Blockchain in healthcare
- Genomic data privacy
- Personal genomics
References
[edit]- ^ a b c Milne, Gemma. "Blockchain Genomics Startup Allows You To Make Money With Your DNA." Forbes, September 26, 2018. [1]
- ^ "Lecture to debate ownership of personal genetic data." The Royal Gazette, March 9, 2023. [2]
- ^ a b c "Stop giving your DNA data away for free to 23andMe, says Genomes.io CEO." Cointelegraph, September 5, 2024. [3]
- ^ a b "DNA Data Shouldn’t Die with 23andMe: Blockchain-based DNA Banks Step In." Cointelegraph, July 2025. [4]
- ^ a b "How Much Is DNA Actually Worth?" WHYY, 2025. [5]
- ^ a b "Decentralized Autonomous Organizations in Biotech." Labiotech.eu, 2023. [6]
- ^ "Genomes.io Wins the Deloitte Tech Fast 50 Challenge Award." Newswire, November 21, 2022. [7]
- ^ a b "Decentralization is helping to shape the course of scientific research and business." Cointelegraph, August 2023. [8]
- ^ Yang Tho, Eldrian J., and Angela Meilan Farese. “A Future with Decentralised Science.” Felix Online (Imperial College London), November 8, 2024. https://felixonline.co.uk/articles/future-of-decentralised-science/.
- Promotional tone, editorializing and other words to watch
- Vague, generic, and speculative statements extrapolated from similar subjects
- Essay-like writing
- Hallucinations (plausible-sounding, but false information) and non-existent references
- Close paraphrasing
Please address these issues. The best way is usually to read reliable sources and summarize them, instead of using a large language model. See our help page on large language models.